Profilo
David K.
Lee currently works at Servier Pharmaceuticals LLC, as Chief Executive Officer from 2018.
Mr. Lee also formerly worked at iTeos Therapeutics, Inc., as Independent Director from 2023 to 2025 and Shire International GmbH (Switzerland), as Global Head-Oncology & Rare Diseases from 2015 to 2018.
Mr. Lee received his undergraduate degree from Harvard University and Masters Business Admin degree from Harvard Business School.
Posizioni attive di David Lee
| Società | Posizione | Inizio |
|---|---|---|
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Amministratore Delegato | 01/09/2018 |
Precedenti posizioni note di David Lee
| Società | Posizione | Fine |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/08/2025 |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | 01/09/2018 |
Formazione di David Lee
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Health Technology |
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Health Technology |
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
















